Author:
Chang J.,Powles T.J.,Ashley S.E.,Iveson T.,Gregory R.K.,Dowsett M.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Early Breast Cancer Trialists' Collaborative Group E: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339: 1–15, 1992
2. Powles TJ, Hickish T: Tamoxifen therapy and carcinogenic risk (Editorial). J Natl Cancer Inst 87(18): 1343–1344, 1995
3. Han X, Liehr JG: Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res 52: 1360–1363, 1992
4. White I, de Matteis F, Davies A, et al.: Genotoxic potential of tamoxifen and analogues in female Fisher 344/n rats, DBA/2 and C57B2/6 mice, and in human MCL/5 cells. Carcinogenesis 13: 2197–2203, 1992
5. Phillips D, Potter G, Horton M, et al.: Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates alpha-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen. Carcinogenesis 15: 1487–1492, 1994
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献